HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
IRWD
Ironwood Pharmaceuticals Inc - Class A
Healthcare Drug Manufacturers - Specialty & Generic · Massachusetts, USA · Reports in usd
Market Cap: $639.3M
Market Cap
$639.3M
Enterprise Val
$1.02B
P/E Ratio
26.62
P/B Ratio
-2.44
Trailing PEG (1Y)
-0.18
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$261.8M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity-8.22%
Return on Assets6.57%
Current Ratio1.13
Debt/Equity-2.28
LT Debt/Equity-1.51
Revenue Per Share0.29

Income Statement

Dec 31, 2025
Revenue$47.7M
Cost of Revenue$0.00
Gross Profit$47.7M
R&D$21.9M
SG&A$19.3M
Operating Expenses$40.9M
Operating Income$6.8M
Interest Expense$7.9M
Tax Expense$2.7M
Net Income-$2.3M
EPS (Basic)$-0.01
EPS (Diluted)$-0.01
EBIT$8.3M
EBITDA$9.2M
Consolidated Income-$2.3M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$215.5M
Accounts Receivable$46.7M
Inventory$0.00
Current Assets$274.2M
LT Investments$0.00
Property, Plant & Equipment$12.7M
Intangibles$2.0M
Non-Current Assets$122.7M
Total Assets$396.9M
Accounts Payable$2.9M
Current Debt$202.9M
Current Liabilities$242.2M
LT Debt$394.9M
Non-Current Liabilities$416.5M
Total Liabilities$658.7M
Total Debt$597.8M
Retained Earnings-$1.67B
Shareholder Equity-$261.8M
Shares Outstanding162,678,647

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$74.6M
Investing Cash Flow$1.0K
Financing Cash Flow$122.0K
CapEx$1.0K
Free Cash Flow$74.6M
Depreciation & Amort.$895.0K
Stock-Based Comp$3.8M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$122.0K
Dividends Paid$0.00
Net Change in Cash$75.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h